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Polyoxometalates (POMs) are a class of transition-metal oxide clusters with significant 
applications in material science as well as in biomedical field. Recently, it has been 
reported that POMs exhibit antitumor activity. POMs containing molybdenum (Mo), 
tungsten (W), and vanadium (V) with oxygen are three types of POMs with different 
structural features introduced by our lab as a novel inorganic chemotherapeutic agent for 
cancer treatment. In this study, Vanadium polyoxometalate (V-POM), which exhibited 
highest cytotoxicity in 5 different cancer cell lines in our previous in vitro experiment, 
was incorporated with Gelatin type B through polymer modification in hopes of 
prolonging circulation time and avoiding undesired toxicity. The stability, cellular 
uptake, and cytotoxicity of the V-POM/gelatin nanoparticles were investigated in vitro. 




Despite the many progresses that were made in medical field last decades, providing 
effective treatment for cancer still remains as unsolved challenge. As baby boomers are 
slowly but surely reaching end of their years and as death due to cancer reached 2
nd
 
highest in cause of death in United States, right after heart diseases, development of a 
novel treatment for cancer remains as utmost desired, yet challenging pursuit. Most of the 
cancer therapeutics that are mainly used and studied is organic compounds. Interestingly 
enough, cisplatin, currently the biggest selling anti cancer drug, is an inorganic complex. 
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With that considered, there are merits in studying POMs as a novel inorganic compound 
for anti-cancer applications.  
Polyoxometalates are a transition-metal oxide clusters formed of metal cations connected 
by oxide anions. Numerous POMs has been synthesized and evaluated, but its potential 
application in medical field is still rudimentary. Interesting characteristics of POMs are 
its high antitumoral properties. In the studies, anti-tumor activity of  was 
found to be better than that of the most prevalent drug, cisplatin. Polyoxometalate 
synthesized in our lab, { } triesters POMs, also showed better antitumoral activities in 
inducing tumor growth in in vivo model. Despite its significant potency, there has only 
been one polyoxometalate compound that has been tested on human subject, and due to 
the high toxicity associated with the compound, its potential application in medicinal 
field has drastically retracted. The side effects associated with application of POMs is 
likely due to its instability in water at physiological pH, which results in degradation of 
polyoxmetalates into smaller inorganic products. Its cellular toxicity may also contribute 
in deterring its application. However, by combining POMs with the biopolymer, such as 
gelatin, it is possible to improve its physiological stability as well as its toxicity through 
the modification of its surface charge, polarity, redox potential, etc.  
Gelatin is a well-known natural polymer that has ideal properties in synthesizing 
Gelatin/POM nanoparticles. With both amino and carboxyl groups on its chain, it is 
highly biocompatible, since similar proteins are also synthesized in our bodies, and its 
zwitterionic nature allows simple procedure of polymer modification without large 
amount of surfactant or harmful organic solvents. Because of the zwitterionic nature of 
gelatin, the positively charged portion of the gelatin forms hydrophobic complex with 
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anionic V-POM while the anionic part of the gelatin stabilizes the newly formed particle 
through electrostatic repulsion.  
In this study, V-POMs are dye labeled with Alexa Fluor
®
 488 Dye (Life Technologies 
Corp.) for cellular internalization purposes, which results in POM conjugates with 4 
negative charges. For Gelatin, bovine, type B with approximately 225 g bloom, about 
average molecular weight of 50,000 is used. These particles are used to form 
polymer/POM hybrid nanoparticles through polymer modification where its improvement 
on stability, cytotoxicity, and internalization will be measured and compared to V-POM 
alone. 
 
2. Experimental  
2.1   Preparation of Gelatin/POM nanoparticles 
Three ratios of Gelatin/POM nanoparticles are synthesized: 1:0.5, 1:1, and 1:2. Gelatin 
solution (60 ml), containing 50 mg of gelatin was prepared and warmed to 70ºC. An 
aqueous solution of V-POM (2 ml) was prepared by dissolving appropriate amount of 
POMs (based on the ratio) in the mixture solution of  0.05 ml of DMSO, and 1.95 ml of 
water. Aqueous V-POM was then added to gelatin solution dropwise at 0.1 ml/hr. During 
the process, the mixture was continually stirred at 500 rpm and kept at 70 ºC. After 24 
hours of stirring, the mixture was put in freezer for next 24 hours. The gelatin/POM 
hybrid mixture was then put in process of lyophiliazation to remove all the water and 
obtain gelatin/POM hybrid nanoparticles in solid form. 
 2.2   Stability 
Stability of gelatin/POM nanoparticles and V-POM was measured by a UV spectrometer 
(UV0810M232, CARY
®
). Gelatin/POM hybrid nanoparticles and V-POM were diluted 
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in phosphate buffered solution (1.5ml). Because V-6 POM does not readily dissolve in 
PBS, minimal amount of DMSO was added to dissolve V-POM. Same amount of DMSO 
were added to hybrid nanoparticles for control. Each solution was further diluted until its 
maximum absorbance was between  0.8 to 1. The absorbance was measured every other 
day for a week. The wavelength was set between 200 nm and 800 nm and PBS was used 
as blank. All the solutions and control were kept at 32 ºC.  
 2.3   Cytotoxicity 
Crystal violet assay was used to evaluate cytotoxicity of hybrid nanoparticles in 
comparison to POM alone. SKOV-3 human ovarian carcinoma cell line was used in this 
in vitro study, since V-POM showed highest anti-cancer activity against this cancer cell 
line. SKOV-3 cell line was maintained in McCoy’s 5A medium (Cellgro
®
, Manassas, 
VA) supplemented with 10% FBS (Thermo Fisher Scientific Inc., Waltham, MA, USA) 
and 100 U/mL penicillin and 100 µg/mL streptomycin (cellgro
®
, Manassas, VA) . The 
sample size was set as n = 4 and nanoparticles and POMs were diluted to 2, 20, and 200 
µM with culture medium. With 12 wells as control, total of 60 wells of well plates were 
used. For cell seeding, 4,000 cells were seated in 100 µl of McCoy’5A per well. After 24 
hours, 100 µl of drug was treated to the treatment group and 100 µl of McCoy was 
treated to control group. After 72 h-incubation, the plate was washed and fixed with 4% 
formaldehyde for 10 minutes. After washing with PBS, it was stained with 0.5% crystal 
violet. After 20-30 minutes of incubation at RT, it was washed with tap water twice. 
After air drying for a day, the dye is solubilized with Sorenson’s buffer and the 
absorbance was read by a microplate reader (Synergy 2, BioTek
®
)at 570 nm. 
 2.4   Internalization 
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For internalization, an 8-chamber slide (Lab Tek
TM
, Naperville, IL) was used. The 4,000 
cells were seated per well. After 24 hours of incubation, each well was treated with Alexa 
488 Dye-labeled nanoparticles or Alexa 488 Dye-labeled POM at 0.5 or 1 µM. After 72 
h-incubation, the plate was washed and fixed with 4% formaldehyde. After that, the slide 
was mounted with Prolong Gold® Antifade Reagent with DAPI (Life Technologies 





3. Results and discussion 
3.1   Preparation of gelatin/POM nanoparticles 
Because gelatin has zwitterionic properties while POM has anionic properties, positive 
part of gelatin and anionic nature of POM forms hydrophobic complex through 
electrostatic attraction while the anionic part of the gelatin provides stabilization through 
electrostatic repulsion. Conceptually, by controlling the surface charge of the POM, 
proper hybrid nanoparticles should form and cellular toxicity should decrease. Further 
study would involve characterizing the nanoparticles, including its relative size and pH 
based on the ratio and visualization through transmission electron microscopy. 
 3.2   Stability 
For the stability, two of the nanoparticles with ratio of 1:1 and 1:2, clearly demonstrated 
overall improvement in stability while nanoparticle with ratio 1:0.5 and POM alone 
stability seemed similarly distraught. Nanoparticle with ratio of 1:2 definitely showed 
highest stability, as the highest peak remained in same wavelength and second peak 
remained insignificant. For Nanoparticle with ratio of 1:1, the wavelength of highest peak 
remained constant but the absorbance increased by 20% over the period of 7 days. For 
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nanoparticles with 1:0.5 ratio, the second highest peak increased by several fold by day 7 
where its absorbance surpassed that of the original highest peak. There seemed to be 
overall trend that with higher the ratio of POM to Gelatin, better the stability. Further 
study may include synthesis of nanoparticles with ratio of 1:5, 1:10, etc. 
 3.3   Cytotoxicity 
For the cell viability test, overall, all three ratios of nanoparticles performed better than 
V-POM alone. Similar to the result of stability, nanoparticle with ratio of 1:2 induced 
greatest cell death in both 1 µM and 10 µM. At the concentration of 10 µM, the 
nanoparticle with ratio of 1:2 induced cell death by approximately 80% on average, while 
75% of the cells in V-POM treatment group died on average. For 1 µM, which was the 
lowest concentration, 1:2 induced cell death by 75 % on average, while V-POM at the 
lowest concentration only induced cell death by 50%, which showed at lower 
concentration, nanoparticles clearly outperformed V-POM alone. Statistically, the p-
value is less than 0.05, which means the difference is considered to be statistically 
significant. Strangely, nanoparticle with 1:2 ratio did not perform so well on highest 
concentration of 100 µM compared to other nanoparticles and V-POM. (Note for this part 
of the experiment, equal amount of POMs in nanoparticles were treated to cells, so that 
equal amount of V-POMs in nanoparticles and POM are treated to cells.) Further study 
include toxicity test of nanoparticles to normal cell line must be conducted to evaluate the 
cellular toxicity the POM possess and ability of polymer modification to deduce the 
toxicity.   
 3.4   Internalization 
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For the internalization, the green images display the nanoparticles inside and outside the 
cell while blue image display the nucleus of the cell. The superimposed image reveals 
that the fluorescently dyed nanoparticles and V-POM is in cytoplasm and inside the 
nucleus. Not surprisingly, nanoparticle with ratio of 1:2 exhibited highest internalization. 
Compared to images of other nanoparticles and complex at 0.5 µM, the background of 
the fitc image of 1:2 ratios is dark, while other has green hues. Assuming no leakage has 
occurred and drug is well spread inside the well, because equal amount of fluorescently 
dyed POM entered the well, it is safe to assume that most of the drug has entered the 
cancer cells. Correlation with the other 2 results revealing optimal result in nanoparticle 
with ratio of 1:2 further supports the need of further need in synthesizing and evaluating 
the efficacy of nanoparticles with higher ratio in POM.  
 
4. Conclusion 
 As cancer will likely be a rising problem in the medical field, need for early 
detection method and innovative treatment is needed. Polyoxometalate is a complex that 
is novel in field of medicine. Although it has failed human trial due to the associated side 
effects, other studies and this paper show that the associated problems could be severely 
diminished through polymer incorporation. By utilizing flexible properties of polymers, 
such as gelatin, the stability could be highly prolonged while increasing anti-cancer effect 
and internalization. The actual cause of cell death due to POM is still unidentified; 
therefore, further study must be done on the exact mechanism behind how it induces cell 
death. Through understanding of its mechanism, it may be possible to have better control 




FIGURE I: STABILITY 














Figure 1. Stability of (a) 1:.05, (b)1:1, (c) 1:2, (d) POM over wavelength of 200nm to 
800nm. First peak on all four nanoparticles were diluted until absorbance was in range 























Figure II. Cytotoxicity of POM, 1:.0.5, 1:1, 1:2 nanoparticles against human cancer cell 




























FIGURE III: INTERNALIZATION 
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Figure III. Internalization of Alexa 488-labelled V-POM into SKOV-3 cells. SKOV-3 
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